Suman Siddamreddy
Suman Siddamreddy publishes mostly in Neurology, Infectious Diseases and Economics and Econometrics, on topics such as Long-Term Effects of COVID-19, COVID-19 Clinical Research Studies and Pharmaceutical industry and healthcare.
- World rank
- #4,809,449 of 7,710,434 ranked researchers
- Rank in United States
- #1,259,853 of 1,627,098
- Works
- 30
- Citations
- 491
- Citations per work
- 16.4
What does Suman Siddamreddy research?
Suman Siddamreddy's work is mostly in Medicine (41%), Economics, Econometrics and Finance (9%), Pharmacology, Toxicology and Pharmaceutics (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1344.9%
- Health Sciences1241.3%
- Medicine1241.3%
- Social Sciences39.2%
- Life Sciences14.6%
- 1Neurology16% of their works
- 2Infectious Diseases13% of their works
- 3Economics and Econometrics9% of their works
- 4Epidemiology8% of their works
- 5Oncology5% of their works
- 6Pharmacology5% of their works
Research topics
- Long-Term Effects of COVID-19
- COVID-19 Clinical Research Studies
- Pharmaceutical industry and healthcare
- Health Systems, Economic Evaluations, Quality of Life
- Acute Ischemic Stroke Management
- Pharmaceutical Economics and Policy
- Inflammatory Myopathies and Dermatomyositis
- Peripheral Neuropathies and Disorders
Which keywords describe Suman Siddamreddy's research?
The keywords of their largest research topics: Neurologic Manifestations, Post-acute COVID-19 Syndrome, Clinical Characteristics, SARS-CoV-2, Pharmaceutical Industry, Conflict of Interest, Cost-effectiveness Analysis and Quality of Life.
- Inflammatory Myopathies
- Dermatomyositis
- Thrombolysis
- Generic Drugs
- Treatment
- Quality of Life
- Conflict of Interest
- SARS-CoV-2
- Post-acute COVID-19 Syndrome
- Neurologic Manifestations
- Clinical Characteristics
- Pharmaceutical Industry
- Cost-effectiveness Analysis
- Research Outcome
- Drug Development Costs
- Ischemic Stroke
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Guillain-Barré Syndrome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Neurologic Manifestations111 topic
- Post-acute COVID-19 Syndrome111 topic
- Clinical Characteristics81 topic
- SARS-CoV-281 topic
- Pharmaceutical Industry72 topics
- Conflict of Interest41 topic
- Cost-effectiveness Analysis41 topic
- Quality of Life41 topic
- Research Outcome41 topic
- Treatment42 topics
- Drug Development Costs31 topic
- Generic Drugs31 topic
- Ischemic Stroke31 topic
- Thrombolysis31 topic
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy21 topic
- Dermatomyositis21 topic
- Guillain-Barré Syndrome21 topic
- Inflammatory Myopathies21 topic
Where does Suman Siddamreddy work?
Suman Siddamreddy's main affiliation in the publication record is Baptist Health Foundation, United States.
How many publications and citations does Suman Siddamreddy have?
OpenAlex counts 30 works and 491 citations for Suman Siddamreddy, an h-index of 9, ranking #4,809,449 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Suman Siddamreddy. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.